ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HROW Harrow Inc

10.53
0.53 (5.30%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 608,714
Bid Price 10.00
Ask Price 10.76
News -
Day High 10.71

Low
7.60

52 Week Range

High
28.25

Day Low 10.06
Company Name Stock Ticker Symbol Market Type
Harrow Inc HROW NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.53 5.30% 10.53 16:34:30
Open Price Low Price High Price Close Price Prev Close
10.12 10.06 10.71 10.53 10.00
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6,219 608,714 $ 10.45 $ 6,359,988 - 7.60 - 28.25
Last Trade Time Type Quantity Stock Price Currency
16:48:24 1 $ 10.53 USD

Harrow (HROW) Options Flow Summary

Overall Flow

Bearish

Net Premium

-28k

Calls / Puts

0.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Harrow Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
867.76M 35.12M - 130.19M -24.41M -0.70 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Harrow News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No HROW Message Board. Create One! See More Posts on HROW Message Board See More Message Board Posts

Historical HROW Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week10.7111.239.8610.35556,313-0.18-1.68%
1 Month13.5213.739.8611.81412,502-2.99-22.12%
3 Months9.4613.739.1311.30479,6571.0711.31%
6 Months14.1114.857.6010.58546,579-3.58-25.37%
1 Year24.2028.257.6014.40537,137-13.67-56.49%
3 Years8.3328.255.4013.50303,6962.2026.41%
5 Years4.8528.253.3311.33258,6335.68117.11%

Harrow Description

Harrow Health Inc is an ophthalmology-focused pharmaceutical company. The company is specialized in the development, production, and sale of medications that offer competitive advantages and serve unmet needs in the marketplace. Its cornerstone of ophthalmology program consists of proprietary Dropless Therapy injectable and LessDrops topical formulations that are designed to address patient compliance issues and provide other compelling medical and economic benefits.

Your Recent History

Delayed Upgrade Clock